PYC Therapeutics Limited (ASX:PYC)
Australia
· Delayed Price · Currency is AUD 1.220
-0.030 (-2.40%)
Mar 31, 2025, 4:11 PM AEST
PYC Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 49.25 | 66.87 | 15.57 | 29.11 | 18.44 | 7.24 | Upgrade
|
| Short-Term Investments | - | - | - | - | 33.07 | 18.19 | Upgrade
|
| Cash & Short-Term Investments | 49.25 | 66.87 | 15.57 | 29.11 | 51.5 | 25.43 | Upgrade
|
| Cash Growth | 93.81% | 329.47% | -46.51% | -43.48% | 102.54% | 311.36% | Upgrade
|
| Accounts Receivable | 12.27 | - | - | - | - | - | Upgrade
|
| Other Receivables | - | 18 | 16.25 | 10.07 | 0.19 | 0.08 | Upgrade
|
| Receivables | 12.27 | 18 | 16.25 | 10.07 | 0.19 | 0.08 | Upgrade
|
| Other Current Assets | 0.61 | 0.74 | 0.05 | 0.07 | 0.09 | 0.05 | Upgrade
|
| Total Current Assets | 62.12 | 85.61 | 31.87 | 39.25 | 51.78 | 25.56 | Upgrade
|
| Property, Plant & Equipment | 2.15 | 1.57 | 1.04 | 1.63 | 1.49 | 1.14 | Upgrade
|
| Other Intangible Assets | 3.95 | 4.05 | 4.25 | 4.45 | 4.65 | 4.85 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.02 | 0.02 | - | Upgrade
|
| Total Assets | 68.23 | 91.24 | 37.17 | 45.35 | 57.94 | 31.55 | Upgrade
|
| Accounts Payable | 9.92 | 7.53 | 4.92 | 2.57 | 2.35 | 0.1 | Upgrade
|
| Accrued Expenses | 1.07 | 1.26 | 3.15 | 1.38 | 0.61 | 0.38 | Upgrade
|
| Current Portion of Leases | 0.38 | 0.31 | 0.18 | 0.26 | 0.19 | 0.15 | Upgrade
|
| Other Current Liabilities | - | 0.01 | 0.15 | 0.17 | 0.16 | 0.07 | Upgrade
|
| Total Current Liabilities | 11.38 | 9.11 | 8.41 | 4.39 | 3.3 | 0.71 | Upgrade
|
| Long-Term Leases | 0.83 | 0.8 | 0.14 | 0.68 | 0.54 | 0.65 | Upgrade
|
| Total Liabilities | 12.52 | 10.18 | 8.72 | 5.15 | 4.02 | 1.35 | Upgrade
|
| Common Stock | 230.58 | 230.58 | 140.09 | 125.99 | 125.99 | 87.21 | Upgrade
|
| Retained Earnings | -181.47 | -155.89 | -118.17 | -95.38 | -81.52 | -63.75 | Upgrade
|
| Comprehensive Income & Other | 6.33 | 5.81 | 5.83 | 8.74 | 8.57 | 5 | Upgrade
|
| Total Common Equity | 55.44 | 80.5 | 27.75 | 39.35 | 53.04 | 28.45 | Upgrade
|
| Minority Interest | 0.27 | 0.56 | 0.69 | 0.85 | 0.88 | 1.74 | Upgrade
|
| Shareholders' Equity | 55.7 | 81.05 | 28.44 | 40.2 | 53.92 | 30.2 | Upgrade
|
| Total Liabilities & Equity | 68.23 | 91.24 | 37.17 | 45.35 | 57.94 | 31.55 | Upgrade
|
| Total Debt | 1.21 | 1.11 | 0.32 | 0.94 | 0.73 | 0.8 | Upgrade
|
| Net Cash (Debt) | 48.04 | 65.76 | 15.26 | 28.17 | 50.77 | 24.63 | Upgrade
|
| Net Cash Growth | 93.19% | 331.05% | -45.84% | -44.52% | 106.14% | 298.45% | Upgrade
|
| Net Cash Per Share | 0.11 | 0.17 | 0.05 | 0.09 | 0.16 | 0.09 | Upgrade
|
| Filing Date Shares Outstanding | 466.61 | 466.61 | 373.29 | 318.09 | 318.09 | 293.16 | Upgrade
|
| Total Common Shares Outstanding | 466.61 | 466.61 | 341.65 | 318.09 | 318.09 | 293.16 | Upgrade
|
| Working Capital | 50.75 | 76.51 | 23.47 | 34.86 | 48.48 | 24.86 | Upgrade
|
| Book Value Per Share | 0.12 | 0.17 | 0.08 | 0.12 | 0.17 | 0.10 | Upgrade
|
| Tangible Book Value | 51.49 | 76.45 | 23.5 | 34.9 | 48.39 | 23.6 | Upgrade
|
| Tangible Book Value Per Share | 0.11 | 0.16 | 0.07 | 0.11 | 0.15 | 0.08 | Upgrade
|
| Machinery | - | 3.55 | 3.24 | 2.81 | 2.43 | 1.81 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.